Why Changes are needed to Current Preformulation and Formulation Practices




Pharmaceuticals & Biotechnology | Pharma & Biotech Resources show

Summary: As part of the Pharma Leaders Today Series Dr. Keith Horspool, Vice President, Pharmaceutical Development US, Boehringer Ingelheim, speaks to Andrea Charles from Pharma IQ , about why changes are needed to current preformulation and formulation practices, strategies to reduce